GENESYS2023-04-012023-06-30 GENESYS2023-04-012023-06-30in-bse-fin:OneOperatingExpenses01Member GENESYS2023-06-30 GENESYS2023-04-012023-06-30in-bse-fin:OneItemsThatWillNotBeReclassifiedToProfitAndLoss01Member GENESYS2023-04-012023-06-30in-bse-fin:OneItemsThatWillBeReclassifiedToProfitAndLoss01Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares 506109 GENESYS NOTLISTED Genesys International Corporation Limited Equity 2023-04-01 2024-03-31 2023-08-14 2023-08-08 INR Lakhs First quarter 19:15:00 21:20:00 2023-08-14 2023-08-14 Not applicable Single segment Geographical information system 2023-04-01 2023-06-30 Unaudited Consolidated 345477000.00 9250000.00 354727000.00 127402000.00 0.00 0.00 115055000.00 6651000.00 113004000.00 44977000.00 407089000.00 -52362000.00 0.00 -52362000.00 1478000.00 800000.00 2278000.00 0.00 -54640000.00 0.00 0.00 0.00 0.00 -54640000.00 -4957000.00 -59597000.00 -53303000.00 -1337000.00 -58203000.00 -1394000.00 188870000.00 5 -1.40 -1.40 0.00 0.00 -1.40 -1.40 1. The Group is engaged in providing advanced geospatial content and solutions including 3D mapping. 2. The Group operates only in one Segment i.e. GIS based services for the purpose of IND AS – 108 Segmental reporting, hence disclosure as per IND AS 108 'Operating Segment' is not required. 3. The consolidated financial results for the quarter ended June 30, 2023 have been duly reviewed by the Audit Committee and approved by the Board of Directors at its meeting held on August 14, 2023. The Statutory auditors of the Genesys International Corporation Limited ( The Holding Company ) have expressed an unmodified opinion on the above consolidated results. These unaudited Consolidated financial results have been prepared in accordance with the recognition and measurement principles provided in Indian Accounting Standard (Ind AS) 34 on 'Interim Financial Reporting', the provisions of the Companies Act, 2013 (the Act), as applicable and guidelines issued by the Securities and Exchange Board of India (SEBI) under SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, as amended. 4. The Board of Directors of the Company in its meeting held on 19 December 2022, has, subject to necessary approvals / consents / sanctions of the shareholders, Stock Exchanges where shares of the Company are listed, Hon’ble National Company Law Tribunal (NCLT), and other relevant appropriate authorities, approved the Scheme of Amalgamation for merger of its Wholly Owned Subsidiary, Virtual World Spatial Technologies Private Limited (Transferor Company), with Genesys International Corporation Limited (Transferee Company), to consolidate and effectively manage the Transferor and Transferee Companies as a single entity. Accordingly, an application under section 230 to 232 of the Companies Act, 2013 has been filed with Hon’ble NCLT, Mumbai to approve the Scheme of Amalgamation and related matters. Appointed date is 1 April 2023. The Scheme shall be made effective from the Appointed date on sanction of Scheme by Hon’ble NCLT and subject to such conditions or guidelines as the Hon’ble NCLT may stipulate in this regard. 5. The figures for the three months ended March 31, 2023 are arrived as difference between audited figures in respect of the full financial year and the unaudited published figures upto nine months of the relevant financial year, which were subject to limited review. 6.The Holding Company has incorporated a new wholly owned subsidiary Genesys Middle East Limited during the quarter. 7. Previous period/year figures have been re-grouped, re-arranged and re-classified wherever necessary to conform to current period's classification. Other Expenses 44977000.00 Remeasurement of the net defined benefit liability / asset (Net of taxes) -1212000.00 -1212000.00 0.00 Exchange differences on translation of financial statements of foreign operations -3745000.00 -3745000.00 0.00